TMCnet News
Zai Lab Announces Presentations at June ConferencesSHANGHAI, China, May 29, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that members of the senior management team will be attending the following upcoming conferences in June. Details of the conferences are as follows:
Individuals may access a live webcast of the Jeferies 2019 Healthcare Conference presentation on the Zai Lab website at www.zailaboratory.com under "Events & Presentations" in the "Investor Relations" section. A replay of the webcast will be available on this site for 30 days following the live event. About Zai Lab Zai Lab (NASDAQ: ZLAB) is a China and US-based innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Zai Lab’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast-growing segments of China's pharmaceutical market and addressing unmet medical needs. Zai Lab's vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners' and its own products in order to impact human health worldwide. Contact: Zai Lab Media: Nancie Steinberg / Robert Flamm Investors: Lee Roth |